VRNCT07884682
Virtual Reality for Pain and Anxiety During Intravenous Catheterization
A study testing virtual reality glass in people with VR and Pain, run by Erzincan Binali Yildirim Universitesi at 1 site in Turkey (Türkiye).
Trial summary
This study was conducted as a quasi-experimental study with a pretest-posttest control group design to determine the effect of using VRG, as a distraction method, on pain, anxiety, oxygen saturation level, and pulse rate during PIC. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- What is being tested?
- virtual reality glass
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 136 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 20 Mar 2025to 30 Aug 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- 18-65 years old,
- had no verbal,
- perceptual, or visual communication difficulties,
- had not taken analgesic medication within the previous 24 hours,
- had no fever at admission,
- reported no acute or chronic pain,
- had no previous history of syncope during PIC insertion
Who cannot join
- requested to leave the study,
- felt unwell during PIC insertion,
- were receiving chemotherapy,
- had a previous surgical procedure in the planned insertion area,
- had scarring, psoriasis, or active dermatitis at the insertion site,
- required more than one attempt for PIC placement, or had undergone an invasive procedure in the same vein within the previous month
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Using Virtual Reality Glasses During Peripheral Intravenous Catheterization on Pain, Anxiety, and Physiological Parameters
This study was conducted as a quasi-experimental study with a pretest-posttest control group design to determine the effect of using VRG, as a distraction method, on pain, anxiety, oxygen saturation level, and pulse rate during PIC.
- Being tested
- virtual reality glass
- Medical subject headings
- Pain, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
virtual reality glassOther
virtual reality glass
| Study group | Role | What they receive |
|---|---|---|
| Virtual Reality During Intravenous Catheterization | Experimental | Not described Receives: Other: virtual reality glass |
| Standard Care During Intravenous Catheterization | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Physiological Symptoms of Anxiety Follow-Up Form
Measured: Before and after the peripheral venous catheter insertion procedure
Visual Analog Scale for Pain
Measured: Before and after the peripheral venous catheter insertion procedure
Visual Analog Scale for Anxiety
Measured: Before and after the peripheral venous catheter insertion procedure
Virtual Reality Glasses Satisfaction Form
Measured: After the peripheral venous catheter insertion procedure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Oct 2026
- Study start20 Mar 2025
- Primary completion30 Aug 2025
- Study completion30 Aug 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for VRStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 136 participants (actual)
Sponsor and investigators
- Lead sponsor
- Erzincan Binali Yildirim Universitesi
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Şengül KORKMAZ BİNAY, Erzincan Binali Yildirim Universitesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07884682
- Sponsor's protocol ID
- EBYU
- Status last verified
- Oct 2026
- First submitted
- 8 Oct 2026
- Last updated
- 20 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Using Virtual Reality Glasses During Peripheral Intravenous Catheterization on Pain, Anxiety, and Physiological Parameters
- ClinicalTrials.gov ID
- NCT07884682
- Acronym / sponsor ID
- EBYU
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 136 participants (actual)
- Lead sponsor
- Erzincan Binali Yildirim UniversitesiUniversity, hospital or other
- Study start
- 20 Mar 2025 (actual)
- Primary completion
- 30 Aug 2025 (actual)
- Study completion
- 30 Aug 2025 (actual)
- First posted
- 20 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study was conducted as a quasi-experimental study with a pretest-posttest control group design to determine the effect of using VRG, as a distraction method, on pain, anxiety, oxygen saturation level, and pulse rate during PIC.
Study design
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Virtual Reality During Intravenous Catheterization | Experimental | Other: virtual reality glass |
| Standard Care During Intravenous Catheterization | No intervention | – |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- 18-65 years old,
- had no verbal,
- perceptual, or visual communication difficulties,
- had not taken analgesic medication within the previous 24 hours,
- had no fever at admission,
Key exclusion criteria (6 listed)
- requested to leave the study,
- felt unwell during PIC insertion,
- were receiving chemotherapy,
- had a previous surgical procedure in the planned insertion area,
- had scarring, psoriasis, or active dermatitis at the insertion site,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| virtual reality glassvirtual reality glass | Other | Virtual Reality During Intravenous Catheterization |
Primary outcome
Physiological Symptoms of Anxiety Follow-Up Form
Time frame: Before and after the peripheral venous catheter insertion procedure
Visual Analog Scale for Pain
Time frame: Before and after the peripheral venous catheter insertion procedure
Visual Analog Scale for Anxiety
Time frame: Before and after the peripheral venous catheter insertion procedure
Virtual Reality Glasses Satisfaction Form
Time frame: After the peripheral venous catheter insertion procedure
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for VR
RecruitingPhase 3
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic
Recruiting
Effects of Virtual Reality Environments on Walking in Adults With and Without Knee Osteoarthritis
Knee Osteoarthritis
Not yet recruiting
VR Mindfulness for People With HIV and Substance Use
HIV, Substance Use (Drugs, Alcohol)
Recruiting
Breathing Meditation and VR Nature Videos in Angiography Patients: Effects on Anxiety, Comfort, and Physiology
Coronary Angiography, Virtual Reality
Recruiting
Virtual Reality Assisted Trauma Focused CBT
PTSD - Post Traumatic Stress Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing virtual reality glass in people with VR and Pain, run by Erzincan Binali Yildirim Universitesi at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Physiological Symptoms of Anxiety Follow-Up Form (time frame: Before and after the peripheral venous catheter insertion procedure). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2026.